SCHEMBL7217262

SCHEMBL7217262

O=C(C1Cc2ccccc2C1)N1CC=C(c2c[nH]c3ccccc23)CC1

nearest known ligand 0.55

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
LMNA P02545 5/20 0.55
KDM4E B2RXH2 3/20 0.55
ALOX15 P16050 3/20 0.55
POLB P06746 2/20 0.55
HTR1A P08908 2/20 0.55
SLC6A4 P31645 1/20 0.55
HTR6 P50406 1/20 0.55
HSD17B10 Q99714 1/20 0.55
L3MBTL1 Q9Y468 1/20 0.55
MAPT P10636 14/20 0.55
TP53 P04637 1/20 0.55
HTT P42858 2/20 0.53
NPC1 O15118 1/20 0.53
RAB9A P51151 1/20 0.53
TDO2 P48775 1/20 0.53
MEN1 O00255 1/20 0.50
KMT2A Q03164 1/20 0.50
DRD2 P14416 1/20 0.50
HTR2A P28223 1/20 0.50

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL18324889 0.90 LMNA (0.58) LMNAKDM4EALOX15POLBHTR1A
SCHEMBL7219966 0.88 MAPT (0.51) LMNAPOLBSLC6A4MAPTTP53
SCHEMBL7440918 0.85 MAPT (0.46) LMNAPOLBMAPTTP53
SCHEMBL7216904 0.84 MAPT (0.42) LMNAKDM4EALOX15POLBHTR1A
SCHEMBL7215851 0.83 MAPT (0.52) LMNAKDM4EALOX15POLBHTR1A
SCHEMBL28097296 0.82 LMNA (0.64) LMNAKDM4EALOX15POLBHTR1A
SCHEMBL11864713 0.81 LMNA (0.66) LMNAKDM4EALOX15POLBHTR1A
SCHEMBL18324901 0.78 LMNA (0.66) LMNAKDM4EALOX15POLBHTR1A
SCHEMBL7916133 0.78 MAPT (0.60) LMNAKDM4EALOX15POLBHTR1A
SCHEMBL31285862 0.78 MAPT (0.60) LMNAKDM4EALOX15POLBHTR1A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 8 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6552044-B2 Dopamine receptors H. LUNDBECK A/S (DK) 2003-04-22 US disclosed
EP-0946542-B1 INDANE OR DIHYDROINDOLE DERIVATIVES LUNDBECK & CO AS H (DK) 2002-10-09 EP disclosed
US-6352988-B2 HIGH AFFINITY FOR D4 RECEPTORS; TREATMENT OF SCHIZOPHRENIA, OTHER PSYCHOSES, ANXIETY DISORDERS, DEPRESSION, ALCOHOL ABUSE, IMPULSE CONTROL DISORDERS, AGGRESSION H. LUNDBECK A/S (DK) 2002-03-05 US disclosed
US-20010021777-A1 Indane or dihydroindole derivatives H. LUNDBECK A/S (DK) 2001-09-13 US disclosed
US-20010020095-A1 Indane or dihydroindole derivatives H. LUNDBECK A/S (DK) 2001-09-06 US disclosed
US-6262087-B1 HAVE HIGH AFFINITY FOR D4 RECEPTORS; USEFUL IN THE TREATMENT OF CERTAIN PSYCHIATRIC AND NEUROLOGIC DISORDERS, INCLUDING PSYCHOSIS, DEPRESSION AND ANXIETY. H. LUNDBECK A/S (DK) 2001-07-17 US disclosed
EP-0946542-A1 INDANE OR DIHYDROINDOLE DERIVATIVES H. LUNDBECK A/S (DK) 1999-10-06 EP disclosed
WO-1998028293-A1 INDANE OR DIHYDROINDOLE DERIVATIVES H.LUNDBECK A/S (DK) 1998-07-02 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20010020095-A1 Indane or dihydroindole derivatives HTR4, GPR4, GPR174 LMNA 4625/4885KDM4E 1773/4885ALOX15 2485/4885
US-20010021777-A1 Indane or dihydroindole derivatives HTR4, GPR4, GPR174 LMNA 4625/4885KDM4E 1773/4885ALOX15 2485/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.